Overview

Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis

Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of the investigational products in the patients with gastritis during their participation in the study.
Phase:
Phase 2
Details
Lead Sponsor:
Green Cross Corporation
Collaborators:
C&R Research, Inc.
CRScube